Get access

Botulinum toxin type A formulations in focal dystonias

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the clinical efficacy, safety and immunogenicity of Botulinum Toxin Type A formulations (Dysport® and Botox®) in the treatment of focal dystonias.

Get access to the full text of this article